Key Record Dates
ClinicalTrials.gov Identifier: | NCT00950300 |
---|---|
Brief Title: | A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer |
First Submitted : | July 30, 2009 |
First Submitted that Met QC Criteria : | July 30, 2009 |
First Posted : | July 31, 2009 (Estimate) |
Results First Submitted : | November 4, 2016 |
Results First Submitted that Met QC Criteria : | November 22, 2016 |
Results First Posted : | January 23, 2017 (Estimate) |
Last Update Submitted that Met QC Criteria : | December 21, 2017 |
Last Update Posted : | January 23, 2018 |